
Shilpan Shah
Physician · Houston Methodist Hospital
Credentials: · · · · · · ·
History
- 2026–Present
- 2005–2008

Research
Targeted therapy for HER2 positive breast cancer
Review · Journal of Hematology & Oncology · 2013 · 59 citations
Cell-free DNA 5-hydroxymethylcytosine is an emerging marker of acute myeloid leukemia
Scientific Reports · 2022 · 24 citations
Case report · Journal of Hematology & Oncology · 2014 · First of 4 authors · 15 citations

7 papers

6 papers
- EB
5 papers · 3 as a fellow
- CY
3 papers

3 papers

3 papers

3 papers · 3 as a resident
- YZ
3 papers
Clinical trials
- 2026–2029
Principal investigator · Not yet recruiting · Phase 2
The Methodist Hospital Research Institute
